Mohammad Hossein Ahmadi

Mohammad Hossein Ahmadi

Auto-generated profile, based on publicly available information

Mohammad Hossein Ahmadi

Clinical Research Development Unit, Velayat Hospital, Qazvin University Of Medical Sciences, Qazvin, Iran

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Epigenomics
Verified
Journal Article
Closed access
FMFaezeh Maroufi
Faezeh Maroufi
AMAmirhosein Maali
Amirhosein Maali
MAMeghdad Abdollahpour-Alitappeh
Meghdad Abdollahpour-Alitappeh
MAMohammad Hossein Ahmadi
Mohammad Hossein Ahmadi
MAMehdi Azad
Mehdi Azad
In the last 2 decades, a wide variety of studies have been conducted on epigenetics and its role in various cancers. A major mechanism of epigenetic regulation is DNA methylation, including aberran...

19 October 2022 in Journal of Parathyroid Disease
Verified
Journal Article
Open access
PDF file
SHSepideh Hajian
Sepideh Hajian
ASAli Sarbazi-Golezari
Ali Sarbazi-Golezari
MKMaryam Karbasi
Maryam Karbasi
SOSONIA OVEISI
SONIA OVEISI
MAMohammad Hossein Ahmadi
Mohammad Hossein Ahmadi
MRMaryam Rajabi
Maryam Rajabi
Introduction: Hematological parameters are raised for classification and determining of prognosis in coronavirus disease 2019 (COVID-19). Objectives: The aim of this study is to determine the relation between severity of the illness and serum level of red cell distribution width (RDW), mean platelet volume (MPV), platelet distribution width (PDW) and platelet large cell ratio (P-LCR) in patients with COVID-19 focusing on severe and critically ill patients. Patients and Methods: In this cross-sectional investigation, we examined the correlation between severity of disease and value of RDW, PDW, P-LCR and MPV in hospitalized patients with COVID-19 in Velayat hospital, located in Qazvin province in Iran from November 2020 to March 2021. According to the clinical characteristics, the patients were divided into two group of severe and critically ill. Patients’ data including age, gender, and the value of RDW, PDW, P-LCR and MPV were extracted from the health information system of our hospital. Then, these parameters were analyzed and compared among the groups. Results: The data of 59 patients were evaluated. The mean age of patients was 62.07 years and 59.3% of these patients were female. Around 64.4 percent of the patients were critically ill. The median the value of RDW in the critically ill group was significantly higher than the severe group (P = 0.009). The value of RDW had a significant positive correlation with the severity of the disease (correlation coefficient: 0.341, P = 0.008). Conclusion: Our data showed that RDW might be helpful to differentiate the critically ill patient with COVID-19 from severe one.